Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
letter
. 2010 Jul 7;48(9):3455–3456. doi: 10.1128/JCM.00760-10

Distribution of Human Commensal Escherichia coli Phylogenetic Groups

Jannine K Bailey 1, Jeremy L Pinyon 1, Sashindran Anantham 1, Ruth M Hall 1,*
PMCID: PMC2937668  PMID: 20610687

Most Escherichia coli infections other than gastrointestinal infections are believed to originate from human fecal flora, and the term “extraintestinal pathogenic Escherichia coli” (ExPEC) was introduced to describe these E. coli strains (13). However, there is an enormous diversity of strains within the species E. coli, making it difficult to clearly identify the potential ExPEC strains among the gut E. coli isolates from healthy people by any simple measure.

One categorization of E. coli isolates that is frequently determined is the phylogenetic group. E. coli strains generally fall into one of four phylogenetic groups—A, B1, B2, and D—and early studies using multilocus enzyme electrophoresis (MLEE) indicated that isolates from human feces are not equally distributed between the groups, with group A predominant, whereas among ExPEC strains, groups B2 and D predominate (see reference 13 and references therein). A subsequent study using a triplex PCR to determine phylogenetic group (1) found a predominance of groups A and B1 (2), and it has become common for authors to state that phylogenetic groups A and B1 “predominate” among commensal E. coli strains.

We have used the same multiplex assay to test 68 distinct E. coli strains recovered from the feces of healthy adults who had not taken antibiotics in the preceding 6 months and found a substantial underrepresentation of the B1 type at 7.4% of isolates (Table 1). This led us to reexamine published data on the distribution of phylogenetic groups among human commensal E. coli isolates. Only data sets that used either a single isolate per individual or a single representative of strains identified by extensive characterization of multiple isolates from the same sample were included, and the total number of isolates listed is 1,889. Specific features of the populations from which samples were collected are listed in the table as footnotes. Comparison of the results of different studies reveals considerable variation in which phylogenetic group is most often encountered, and there is no clear trend toward an excess abundance of groups A and B1 relative to B2 and D. Indeed, B1 is overrepresented (measured as greater than 25% of isolates) in only 5 of the 25 studies listed and is underrepresented in the total at 17.9%. Phylogenetic group A, which currently includes isolates that give no signal with the triplex PCR and may represent distinct types (17), is overrepresented in 16 of 25 studies and in the global total (32.0%). However, phylogenetic group B2 is also overrepresented in 11 studies, including the largest study, which examined 530 isolates. Overall, 29.4% of the total isolates were from group B2.

TABLE 1.

Distribution of phylogenetic groups in commensal E. coli isolates from human feces

Location No. of isolates analyzeda Phylogenetic group
Reference
Incidence (no. of isolates)
% of isolates
A B1 B2 D A B1 B2 D
United States, Sweden 27 12 2 7 6 44.5 7.4 25.9 22.2 1
Paris, France 56 34 7 6 9 61 12.5 10.5 16 2
Olib and Silba, Croatia 57 20 18 11 8 35 32 19 14 2
Dogon, Mali 55 13 32 1 9 24 58 2 16 2
Michigan 88 18 11 42 17 20.5 12.5 47.7 19.3 19
Franceb 25 12 3 5 5 48 12 20 20 7
Tokyo, Japanc 61 17 0 27 17 28 0 44 28 12
Franced 24 6 5 7 6 25 21 29 25 18
Paris, France 27 8 3 10 6 29.6 11.1 37.1 22.2 3
Brest, France 21 3 5 7 6 14.3 23.8 33.3 28.6 3
Brittany, Francee 25 6 6 8 5 24 24 32 20 3
Brittany, Francef 25 8 7 4 6 32 28 16 24 3
French Guyana 93 59 19 3 12 63.4 20.4 3.2 12.9 3
Cotonou, Benin 46 23 15 8 0 50 32.6 17.4 0 3
Bogota, Colombia 28 16 1 7 4 57.1 3.6 25 14.3 3
Minnesotag 71 11 13 38 9 15 18 54 13 15
Canberra, Australia 77 15 9 35 18 19.5 12.4 45.1 22.9 4
Madrid, Spain 38 19 7 4 8 50 18 11 21 6
Swedenh 149 43 16 69 21 29 11 46 14 11
Swedeni 61 28 12 11 10 46 20 18 16 10
Spain 50 10 17 9 14 20 34 18 28 14
United Statesj 530 119 90 191 130 22 17 36 25 5
Spaink 67 37 12 7 11 55 18 10 16 8
Spain 120 40 23 20 37 33 19 17 31 9
Sydney, Australia 68 27 5 19 17 39.7 7.4 27.9 25.0 This study
Global total 1,889 604 338 556 391 32.0 17.9 29.4 20.7
a

Where >1 isolate per subject was used, prior identification of strains had been undertaken.

b

Hospital staff.

c

Hospital food court staff.

d

Pregnant women.

e

Bank and insurance workers.

f

Pig farmers.

g

Newly admitted inpatients with no evidence of acute infection.

h

Infants 0 to 12 months old.

i

Schoolgirls aged 7 to 16 years.

j

Six hundred twenty-two subjects were newly admitted hospital patients, for whom disease status is unknown. The remaining 100 subjects were vegetarians, all from Minnesota and Wisconsin.

k

Subjects had suspected acute cystitis.

The combined data from these 1,889 strains thus reveal that groups A and B2 are both somewhat more abundant (32.0% and 29.4% of the total, respectively) than B1 or D (17.9% and 20.7% of the total, respectively) in human feces, and a similar conclusion has recently been drawn by others (16). While both geographic and temporal variation as well as specific features of the populations used may have influenced the outcome of the various studies, the differences could also simply be a reflection of the enormous overall diversity in the E. coli species pool.

Acknowledgments

The work, J.L.P., and J.K.B. are supported by National Health and Medical Research Council (NHMRC) project grant 512434. R.M.H. is supported by NHMRC Research Fellowship grant 358713. S.A. is supported by an Australian Postgraduate Award.

We thank all of the participants, from whom informed consent was obtained in accordance with the requirements of the Human Ethics Committee approval (04-2008/10778) for the study.

Footnotes

Published ahead of print on 7 July 2010.

REFERENCES

  • 1.Clermont, O., S. Bonacorsi, and E. Bingen. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Duriez, P., O. Clermont, S. Bonacorsi, E. Bingen, A. Chaventre, J. Elion, B. Picard, and E. Denamur. 2001. Commensal Escherichia coli isolates are phylogenetically distributed among geographically distinct human populations. Microbiology 147:1671-1676. [DOI] [PubMed] [Google Scholar]
  • 3.Escobar-Paramo, P., K. Grenet, A. Le Menac'h, L. Rode, E. Salgado, C. Amorin, S. Gouriou, B. Picard, M. Cherif Rahimy, A. Andremont, E. Denamur, and R. Ruimy. 2004. Large-scale population structure of human commensal Escherichia coli isolates. Appl. Environ. Microbiol. 70:5698-5700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Gordon, D. M., S. E. Stern, and P. J. Collignon. 2005. Influence of the age and sex of human hosts on the distribution of Escherichia coli ECOR groups and virulence traits. Microbiology 151:15-23. [DOI] [PubMed] [Google Scholar]
  • 5.Johnson, J. R., M. R. Sannes, C. Croy, B. Johnston, C. Clabots, M. A. Kuskowski, J. Bender, K. E. Smith, P. L. Winokur, and E. A. Belongia. 2007. Antimicrobial drug-resistant Escherichia coli from humans and poultry products, Minnesota and Wisconsin, 2002-2004. Emerg. Infect. Dis. 13:838-846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Machado, E., R. Canton, F. Baquero, J. C. Galan, A. Rollan, L. Peixe, and T. M. Coque. 2005. Integron content of extended-spectrum-β-lactamase-producing Escherichia coli strains over 12 years in a single hospital in Madrid, Spain. Antimicrob. Agents Chemother. 49:1823-1829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Mereghetti, L., J. Tayoro, S. Watt, P. Lanotte, J. Loulergue, D. Perrotin, and R. Quentin. 2002. Genetic relationship between Escherichia coli strains isolated from the intestinal flora and those responsible for infectious diseases among patients hospitalized in intensive care units. J. Hosp. Infect. 52:43-51. [DOI] [PubMed] [Google Scholar]
  • 8.Moreno, E., A. Andreu, C. Pigrau, M. A. Kuskowski, J. R. Johnson, and G. Prats. 2008. Relationship between Escherichia coli strains causing acute cystitis in women and the fecal E. coli population of the host. J. Clin. Microbiol. 46:2529-2534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Moreno, E., J. R. Johnson, T. Perez, G. Prats, M. A. Kuskowski, and A. Andreu. 2009. Structure and urovirulence characteristics of the fecal Escherichia coli population among healthy women. Microbes Infect. 11:274-280. [DOI] [PubMed] [Google Scholar]
  • 10.Nowrouzian, F. L., I. Adlerberth, and A. E. Wold. 2006. Enhanced persistence in the colonic microbiota of Escherichia coli strains belonging to phylogenetic group B2: role of virulence factors and adherence to colonic cells. Microbes Infect. 8:834-840. [DOI] [PubMed] [Google Scholar]
  • 11.Nowrouzian, F. L., A. E. Wold, and I. Adlerberth. 2005. Escherichia coli strains belonging to phylogenetic group B2 have superior capacity to persist in the intestinal microflora of infants. J. Infect. Dis. 191:1078-1083. [DOI] [PubMed] [Google Scholar]
  • 12.Obata-Yasuoka, M., W. Ba-Thein, T. Tsukamoto, H. Yoshikawa, and H. Hayashi. 2002. Vaginal Escherichia coli share common virulence factor profiles, serotypes and phylogeny with other extraintestinal E. coli. Microbiology 148:2745-2752. [DOI] [PubMed] [Google Scholar]
  • 13.Russo, T. A., and J. R. Johnson. 2000. Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J. Infect. Dis. 181:1753-1754. [DOI] [PubMed] [Google Scholar]
  • 14.Sabate, M., E. Moreno, T. Perez, A. Andreu, and G. Prats. 2006. Pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates. Clin. Microbiol. Infect. 12:880-886. [DOI] [PubMed] [Google Scholar]
  • 15.Sannes, M. R., M. A. Kuskowski, K. Owens, A. Gajewski, and J. R. Johnson. 2004. Virulence factor profiles and phylogenetic background of Escherichia coli isolates from veterans with bacteremia and uninfected control subjects. J. Infect. Dis. 190:2121-2128. [DOI] [PubMed] [Google Scholar]
  • 16.Tenaillon, O., D. Skurnik, B. Picard, and E. Denamur. 2010. The population genetics of commensal Escherichia coli. Nat. Rev. Microbiol. 8:207-217. [DOI] [PubMed] [Google Scholar]
  • 17.Walk, S. T., E. W. Alm, D. M. Gordon, J. L. Ram, G. A. Toranzos, J. M. Tiedje, and T. S. Whittam. 2009. Cryptic lineages of the genus Escherichia. Appl. Environ. Microbiol. 75:6534-6544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Watt, S., P. Lanotte, L. Mereghetti, M. Moulin-Schouleur, B. Picard, and R. Quentin. 2003. Escherichia coli strains from pregnant women and neonates: intraspecies genetic distribution and prevalence of virulence factors. J. Clin. Microbiol. 41:1929-1935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Zhang, L., B. Foxman, and C. Marrs. 2002. Both urinary and rectal Escherichia coli isolates are dominated by strains of phylogenetic group B2. J. Clin. Microbiol. 40:3951-3955. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES